Why I'm Buying Amylin Now

I'm following the "buy the busted stocks" instead of breakouts methodology, but breaking a rule on buying individual biotech stocks with today's purchase of Amylin Pharmaceuticals .

FDA Updates Pancreatitis Warning on Diabetes Drug

The FDA is alerting physicians to six reports of hemorrhagic or necrotizing pancreatitis in patients using the diabetes drug exenatide .

U.S. seeks more warnings for Amylin diabetes drug

By Susan HeaveyWASHINGTON - U.S. health regulators warned of more cases of dangerous pancreas inflammation in patients taking Amylin Pharmaceuticals Inc's diabetes drug, Byetta, pounding company shares on fears ...

Deaths from Severe Acute Pancreatitis Reported with Exenatide Use

While FDA alerted health care professionals last fall of a possible connection between the use of exenatide and the development of acute pancreatitis, none of the pancreatitis cases reported to the agency ...

Novo Nordisk A/S Sees No Rise In Pancreatitis From Liraglutide

Denmark's Novo Nordisk said it has seen no evidence of a statistically significant increase in cases of pancreas inflammation in trials of drug candidate liraglutide.

More Pancreatitis Cases With Byetta

Six new cases of pancreatitis in people taking the diabetes drug Byetta have been reported to the U.S. Food and Drug Administration .

Black Box In Byetta's Future?

The worst thing that you can tell a pharmaceutical investor is that the company's biggest revenue driver might be more harmful than the disease it is meant to treat.

Temporal Metabonomic Modeling of L-Arginine-Induced Exocrine Pancreatitis

Web Release Date: August 19, 2008 Temporal Metabonomic Modeling of L -Arginine-Induced Exocrine Pancreatitis Department of Pharmaceutical Chemistry, Semmelweis University, Ho ̃ gyes Endre u. 9, Budapest ...

Byetta May Cause More Severe Forms of Pancreatitis

Within the past year, there have been reports of 6 cases of hemorrhagic or necrotizing pancreatitis in people using Byetta, according to an announcement by the FDA.

FDA seeks stronger warnings for Amylin's Byetta

By Susan HeaveyWASHINGTON - U.S. health regulators are seeking stronger warnings about the risk of pancreatitis after the deaths of two patients taking Amylin Pharmaceuticals Inc's injectable diabetes drug ...